Given my estimated creatinine clearance of 65 mL/min, eGFR of 87 mL/min/1.73 m², and serum creatinine of 77 µmol/L, is it safe to continue a daily dose of 120 mg elemental magnesium glycinate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Your Kidney Function is Normal and 120 mg Daily Magnesium Glycinate is Safe

With your eGFR of 87 mL/min/1.73 m² and creatinine clearance of 65 mL/min, you have normal to mildly reduced kidney function, and a daily dose of 120 mg elemental magnesium glycinate poses minimal risk for hypermagnesemia.

Understanding Your Kidney Function Numbers

Your kidney function values indicate you are not in a high-risk category:

  • eGFR 87 mL/min/1.73 m²: This is Stage G1 (normal) or G2 (mildly decreased) kidney function
  • Creatinine clearance 65 mL/min: Slightly lower than eGFR, but still well above the danger threshold
  • Serum creatinine 77 µmol/L: Within normal range

The discrepancy between your eGFR and creatinine clearance is common and expected—different equations yield different results, particularly in older adults 1, 2.

Risk Assessment for Magnesium Supplementation

Your Risk is Low Based on Evidence

The most relevant study examining hypermagnesemia risk identified creatinine clearance ≤28.2 mL/min as the critical threshold where hypermagnesemia becomes a significant concern 3. Your creatinine clearance of 65 mL/min is more than twice this threshold, placing you in a low-risk category.

Dose Considerations

The research specifically examined magnesium oxide at doses ≥900 mg/day (which contains approximately 360 mg elemental magnesium) 3. Your dose of 120 mg elemental magnesium is:

  • One-third of the dose associated with increased risk
  • Well below levels that triggered hypermagnesemia even in high-risk patients
  • Within typical supplementation ranges

The Critical Risk Factors You Don't Have

Hypermagnesemia risk increases dramatically when both of these factors are present 3:

  • Creatinine clearance ≤28.2 mL/min (you have 65 mL/min)
  • Magnesium intake ≥900 mg/day of magnesium oxide equivalent (you take 120 mg elemental)

Patients with both risk factors had a 53.1% incidence of hypermagnesemia, while those with creatinine clearance >28.2 mL/min had minimal risk 3.

Guideline-Based Monitoring Recommendations

Current guidelines emphasize monitoring kidney function when using supplements, particularly over-the-counter products 1. For your situation:

  • Monitor eGFR and electrolytes periodically (every 6-12 months is reasonable given your stable kidney function)
  • Watch for symptoms of hypermagnesemia: muscle weakness, nausea, confusion, or irregular heartbeat
  • Inform your physician about all supplements you're taking 1

Important Caveats

Do not exceed the recommended dose 4. If your kidney function declines below 30 mL/min, reassess magnesium supplementation with your physician 4, 3.

The FDA labeling advises consulting with your physician if undergoing treatment 4, which is prudent given that medications or acute illnesses can temporarily affect kidney function.

Clinical Bottom Line

Your kidney function is adequate for safe magnesium glycinate supplementation at 120 mg daily. The evidence shows hypermagnesemia risk becomes clinically significant only when creatinine clearance drops below approximately 28 mL/min, particularly with higher magnesium doses 3. Guidelines support using eGFR for medication and supplement decisions in your range of kidney function 1, 5.

Continue your current dose, maintain routine kidney function monitoring, and alert your healthcare provider if you develop new medical conditions or medications that might affect kidney function.

Related Questions

Can denosumab be administered to a 75-year-old female with reduced estimated glomerular filtration rate (eGFR)?
What is the recommended nitrofurantoin dosage for adults with chronic kidney disease based on estimated glomerular filtration rate (eGFR)?
Can rivaroxaban (Xarelto) 2.5 mg be used in a patient with a serum creatinine of 215 µmol/L (impaired renal function)?
In an 88-year-old patient with an estimated glomerular filtration rate of 28 mL/min/1.73 m² who is taking omeprazole 20 mg daily, does the medication require renal dose adjustment?
Is it appropriate to prescribe tramadol for a patient with an estimated glomerular filtration rate of 45 mL/min?
With normal serum magnesium and normal renal function, is a daily dose of 120 mg elemental magnesium glycinate safe to continue, and should the dose be adjusted?
What are the presentation, diagnosis, and management of Le Fort I, II, and III mid‑facial fractures?
What is the recommended dose, contraindications, and monitoring for castor oil as a laxative?
What are the bedside decision‑making considerations for enteral and parenteral nutrition, including feeding during vasopressor therapy, choice of gastric versus post‑pyloric feeding, and indications for supplemental parenteral nutrition?
Is the kidney function normal for a 62-year-old woman with serum creatinine 77 µmol/L, estimated glomerular filtration rate (eGFR) 87 mL/min/1.73 m², and creatinine clearance 65 mL/min?
When is it appropriate to allow natural death under an advance directive?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.